Rejane Rua

Has grant

PI & Group leader

Aix-Marseille University
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Spatiotemporal control of neuroinfection by meningeal macrophages

Open Date: 2021-05-01

Close Date: 2026-04-30

Grant: Close

CNSentinels

Open Date: 2020-01-01

Close Date:

Grant: Close

MacMeninges

Open Date: 2019-01-01

Close Date: 2021-01-01

Grant: Close

Characterization of meningeal macrophages

Open Date: 2014-01-01

Close Date: 2019-01-01

Grant: Close

Ecole Normale Superieure

Open Date: 2010-01-01

Close Date: 2013-01-01

Articles (10)

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Across the globe, approximately one in 10 babies are born preterm, that is, before 37 weeks of a typical 40 weeks of gestation. Up to 50% of preterm born infants develop brain injury, encephalopathy of prematurity (EoP), that substantially increases their risk for developing lifelong defects in motor skills and domains of learning, memory, emotional regulation, and cognition. We are still severely limited in our abilities to prevent or predict preterm birth. No longer just the “support cells,” we now clearly understand that during development glia are key for building a healthy brain. Glial dysfunction is a hallmark of EoP, notably, microgliosis, astrogliosis, and oligodendrocyte injury. Our knowledge of glial biology during development is exponentially expanding but hasn't developed sufficiently for development of effective neuroregenerative therapies. This review summarizes the current state of knowledge for the roles of glia in infants with EoP and its animal models, and a description of known glial‐cell interactions in the context of EoP, such as the roles for border‐associated macrophages. The field of perinatal medicine is relatively small but has worked passionately to improve our understanding of the etiology of EoP coupled with detailed mechanistic studies of pre‐clinical and human cohorts. A primary finding from this review is that expanding our collaborations with computational biologists, working together to understand the complexity of glial subtypes, glial maturation, and the impacts of EoP in the short and long term will be key to the design of therapies that improve outcomes.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Veronique Miron

Full Professor

University of Toronto

CANADA
View details

Nathalie Pujol

Research Director

Centre d'Immunologie Marseille-Luminy

FRANCE
View details

Sandro Dá Mesquita

Associate Professor

Mayo Clinic

UNITED STATES
View details

Catarina Almeida

Assistant Professor

Universidade de Aveiro

PORTUGAL
View details

Audrey Romano

Assistant professor

Centre d'Immunologie Marseille-Luminy

FRANCE
View details

Marc Dalod

Centre d'Immunologie Marseille-Luminy

FRANCE
View details

Philippe Pierre

Director of Research Team Leader

CNRS Délégation Provence et Corse

FRANCE
View details

Toby Lawrence

Directeur de Recherche

INSERM

FRANCE
View details

Ana-Maria Lennon-Dumenil

Director of the Immunity and Cancer Unit

Institut Curie

FRANCE
View details

Juliette Van Steenwinckel

Head of group research : ROLE OF MICROGLIA AND NEUROPROTECTIVE STRATEGIES IN NEONATAL BRAIN INJURY

INSERM

FRANCE
View details

Pierre Gressens

INSERM

FRANCE
View details